OAS3
Basic information
Region (hg38): 12:112938051-112976460
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the OAS3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 71 | 77 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 71 | 2 | 4 |
Variants in OAS3
This is a list of pathogenic ClinVar variants found in the OAS3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-112938609-G-A | not specified | Uncertain significance (Jun 21, 2021) | ||
12-112938622-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
12-112938651-A-T | not specified | Uncertain significance (Jul 08, 2022) | ||
12-112938654-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
12-112938658-G-C | not specified | Uncertain significance (Aug 11, 2022) | ||
12-112938675-G-A | Benign (Jun 18, 2018) | |||
12-112938687-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
12-112938688-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
12-112941570-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
12-112941673-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
12-112941756-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
12-112941785-C-G | not specified | Uncertain significance (Jan 22, 2024) | ||
12-112941787-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
12-112941844-A-G | not specified | Uncertain significance (May 08, 2024) | ||
12-112944518-C-G | not specified | Uncertain significance (May 24, 2024) | ||
12-112944521-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
12-112944547-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
12-112944550-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
12-112944598-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
12-112944644-A-G | not specified | Uncertain significance (May 16, 2023) | ||
12-112946795-A-G | not specified | Uncertain significance (Jan 19, 2022) | ||
12-112946824-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
12-112946932-G-A | not specified | Uncertain significance (Jul 13, 2022) | ||
12-112946950-C-A | not specified | Uncertain significance (Sep 07, 2022) | ||
12-112946951-A-G | not specified | Uncertain significance (Dec 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
OAS3 | protein_coding | protein_coding | ENST00000228928 | 16 | 34898 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.97e-33 | 0.0000182 | 121765 | 21 | 2909 | 124695 | 0.0118 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.255 | 597 | 615 | 0.971 | 0.0000369 | 7011 |
Missense in Polyphen | 179 | 178.93 | 1.0004 | 2142 | ||
Synonymous | -0.00639 | 265 | 265 | 1.00 | 0.0000159 | 2209 |
Loss of Function | -0.0212 | 50 | 49.8 | 1.00 | 0.00000247 | 532 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00825 | 0.00822 |
Ashkenazi Jewish | 0.0172 | 0.0172 |
East Asian | 0.00531 | 0.00507 |
Finnish | 0.0166 | 0.0165 |
European (Non-Finnish) | 0.0166 | 0.0164 |
Middle Eastern | 0.00531 | 0.00507 |
South Asian | 0.00583 | 0.00580 |
Other | 0.0130 | 0.0128 |
dbNSFP
Source:
- Function
- FUNCTION: Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes preferentially dimers of 2'-5'- oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L. Displays antiviral activity against Chikungunya virus (CHIKV), Dengue virus, Sindbis virus (SINV) and Semliki forest virus (SFV). {ECO:0000269|PubMed:19056102, ECO:0000269|PubMed:19923450, ECO:0000269|PubMed:9880533}.;
- Pathway
- Influenza A - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Measles - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon alpha/beta signaling;Interferon Signaling
(Consensus)
Intolerance Scores
- loftool
- 0.974
- rvis_EVS
- -0.26
- rvis_percentile_EVS
- 34.98
Haploinsufficiency Scores
- pHI
- 0.0941
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.561
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.317
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Oas3
- Phenotype
Gene ontology
- Biological process
- nucleobase-containing compound metabolic process;response to virus;negative regulation of viral genome replication;defense response to virus;interferon-gamma-mediated signaling pathway;type I interferon signaling pathway;regulation of ribonuclease activity
- Cellular component
- extracellular space;nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;intracellular membrane-bounded organelle
- Molecular function
- 2'-5'-oligoadenylate synthetase activity;double-stranded RNA binding;protein binding;ATP binding;metal ion binding